This content is from: European Union

EU strikes balance with new Bolar provision

Europe is following the US example and introducing a Bolar provision to exempt generic research aimed at obtaining regulatory approval. Marjan Noor and Camilla Smith examine the proposal and how it is likely to be implemented by member states

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial